92 related articles for article (PubMed ID: 9459329)
1. Factor XII determinations in the presence and absence of phospholipid antibodies.
Gallimore MJ; Jones DW; Winter M
Thromb Haemost; 1998 Jan; 79(1):87-90. PubMed ID: 9459329
[TBL] [Abstract][Full Text] [Related]
2. An automated chromogenic peptide substrate assay for coagulation factor XII.
Jones DW; Gallimore MJ; Winter M
Blood Coagul Fibrinolysis; 1998 Mar; 9(2):183-7. PubMed ID: 9622217
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to factor XII associated with lupus anticoagulant.
Jones DW; Gallimore MJ; Harris SL; Winter M
Thromb Haemost; 1999 Mar; 81(3):387-90. PubMed ID: 10102466
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis.
Gallimore MJ; Harris SL; Jones DW; Winter M
Thromb Res; 2004; 114(2):91-6. PubMed ID: 15306150
[TBL] [Abstract][Full Text] [Related]
5. Reduction of factor XII in antiphospholipid antibody-positive patients with thrombotic events in the rheumatology clinic.
Takeishi M; Mimori A; Nakajima K; Mimura T; Suzuki T
Clin Rheumatol; 2003 Feb; 22(1):40-4. PubMed ID: 12605317
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors.
Halbmayer WM; Haushofer A; Schön R; Mannhalter C; Strohmer E; Baumgarten K; Fischer M
Thromb Haemost; 1994 Jan; 71(1):68-72. PubMed ID: 8165648
[TBL] [Abstract][Full Text] [Related]
7. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to factor XII are distinct from antibodies to prothrombin in patients with the anti-phospholipid syndrome.
Jone DW; Nicholls PJ; Donohoe S; Gallimore MJ; Winter M
Thromb Haemost; 2002 Mar; 87(3):426-30. PubMed ID: 11916074
[TBL] [Abstract][Full Text] [Related]
9. Factor XII does not initiate prekallikrein activation on endothelial cells.
Røjkjaer R; Hasan AA; Motta G; Schousboe I; Schmaier AH
Thromb Haemost; 1998 Jul; 80(1):74-81. PubMed ID: 9684789
[TBL] [Abstract][Full Text] [Related]
10. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
11. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
12. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
13. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
Arnout J; Meijer P; Vermylen J
Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of two novel mutations (Q421 K and R123P) in congenital factor XII deficiency.
Kanaji T; Kanaji S; Osaki K; Kuroiwa M; Sakaguchi M; Mihara K; Niho Y; Okamura T
Thromb Haemost; 2001 Dec; 86(6):1409-15. PubMed ID: 11776307
[TBL] [Abstract][Full Text] [Related]
15. [Preliminary study on the effects of coagulation factor XII on fibrinolysis].
Hu Y; Wang H; Jiao J; Wang Y; Yu W; Ling X
Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):466-8. PubMed ID: 11877020
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of bradykinin are suppressed in factor XII-deficient mice.
Iwaki T; Castellino FJ
Thromb Haemost; 2006 Jun; 95(6):1003-10. PubMed ID: 16732380
[TBL] [Abstract][Full Text] [Related]
17. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma.
Johne J; Blume C; Benz PM; Pozgajová M; Ullrich M; Schuh K; Nieswandt B; Walter U; Renné T
Biol Chem; 2006 Feb; 387(2):173-8. PubMed ID: 16497149
[TBL] [Abstract][Full Text] [Related]
18. ELISA for determination of total coagulation factor XII concentration in human plasma.
Madsen DE; Sidelmann JJ; Overgaard K; Koch C; Gram JB
J Immunol Methods; 2013 Aug; 394(1-2):32-9. PubMed ID: 23639297
[TBL] [Abstract][Full Text] [Related]
19. Activated factor XII levels are dependent on factor XII 46C/T genotypes and factor XII zymogen levels, and are associated with vascular risk factors in patients and healthy subjects.
Ishii K; Oguchi S; Murata M; Mitsuyoshi Y; Takeshita E; Ito D; Tanahashi N; Fukuuchi Y; Oosumi K; Matsumoto K; Kitajima M; Yamamoto M; Watanabe G; Ikeda Y; Watanabe K
Blood Coagul Fibrinolysis; 2000 Apr; 11(3):277-84. PubMed ID: 10870808
[TBL] [Abstract][Full Text] [Related]
20. [Antiphospholipid antibodies in asymptomatic pediatric patients].
Aguilar Franco C; Lucía Cuesta J
An Esp Pediatr; 2001 May; 54(5):444-9. PubMed ID: 11333473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
